Collegium Pharmaceutical Stock Market Value
| COLL Stock | USD 34.77 0.68 1.92% |
| Symbol | Collegium |
Collegium Pharmaceutical Price To Book Ratio
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 1.29 | Revenue Per Share 16.797 | Quarterly Revenue Growth 0.155 | Return On Assets 0.1028 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Collegium Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Collegium Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Collegium Pharmaceutical.
| 01/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Collegium Pharmaceutical on January 20, 2024 and sell it all today you would earn a total of 0.00 from holding Collegium Pharmaceutical or generate 0.0% return on investment in Collegium Pharmaceutical over 90 days. Collegium Pharmaceutical is related to or competes with Alkermes Plc, Ironwood Pharmaceuticals, Deciphera Pharmaceuticals, Pacira Pharmaceuticals, Eagle Pharmaceuticals, and Neurocrine Biosciences. Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain manag... More
Collegium Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Collegium Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Collegium Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.21 | |||
| Information Ratio | 0.0289 | |||
| Maximum Drawdown | 15.9 | |||
| Value At Risk | (4.04) | |||
| Potential Upside | 2.79 |
Collegium Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Collegium Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Collegium Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Collegium Pharmaceutical historical prices to predict the future Collegium Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0438 | |||
| Jensen Alpha | 0.0306 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0297 | |||
| Treynor Ratio | 0.0777 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Collegium Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Collegium Pharmaceutical Backtested Returns
We consider Collegium Pharmaceutical very steady. Collegium Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0365, which signifies that the company had a 0.0365% return per unit of risk over the last 3 months. We have found thirty technical indicators for Collegium Pharmaceutical, which you can use to evaluate the volatility of the firm. Please confirm Collegium Pharmaceutical's Downside Deviation of 2.21, risk adjusted performance of 0.0438, and Mean Deviation of 1.57 to double-check if the risk estimate we provide is consistent with the expected return of 0.0846%. Collegium Pharmaceutical has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Collegium Pharmaceutical will likely underperform. Collegium Pharmaceutical right now shows a risk of 2.32%. Please confirm Collegium Pharmaceutical downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Collegium Pharmaceutical will be following its price patterns.
Auto-correlation | -0.59 |
Good reverse predictability
Collegium Pharmaceutical has good reverse predictability. Overlapping area represents the amount of predictability between Collegium Pharmaceutical time series from 20th of January 2024 to 5th of March 2024 and 5th of March 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Collegium Pharmaceutical price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Collegium Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.59 | |
| Spearman Rank Test | 0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 2.34 |
Collegium Pharmaceutical lagged returns against current returns
Autocorrelation, which is Collegium Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Collegium Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Collegium Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Collegium Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Collegium Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Collegium Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Collegium Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Collegium Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Collegium Pharmaceutical Lagged Returns
When evaluating Collegium Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Collegium Pharmaceutical stock have on its future price. Collegium Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Collegium Pharmaceutical autocorrelation shows the relationship between Collegium Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Collegium Pharmaceutical.
Regressed Prices |
| Timeline |
Pair Trading with Collegium Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collegium Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Collegium Stock
| 0.87 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.68 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
| 0.61 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
Moving against Collegium Stock
| 0.86 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.81 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.8 | ME | 23Andme Holding | PairCorr |
| 0.79 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.74 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Collegium Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collegium Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collegium Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collegium Pharmaceutical to buy it.
The correlation of Collegium Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collegium Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Collegium Pharmaceutical Correlation, Collegium Pharmaceutical Volatility and Collegium Pharmaceutical Alpha and Beta module to complement your research on Collegium Pharmaceutical. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Collegium Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.